logo

For the Inventor, By the Inventor

Ann Arbor, MI, United States of America

Po-wai Yuen

This inventor holds 40 USPTO granted patents and 14 published patent applications and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Warner-Lambert Company, Northwestern University, Genentech, Inc.. Active years: 1992-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Po-wai Yuen. Retrieved from https://idiyas.com/inventor/po-wai-yuen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 40 

% Patents Active = 72.5

 

Average Co-Inventor Count = 3.0

ph-index = 10

Forward Citations = 392(Granted Patents)


Company Filing History:

goldMedal26 out of 2,538 
 
Warner-Lambert Company
 patents
silverMedal9 out of 2,220 
 
Northwestern University
 patents
bronzeMedal3 out of 3,300 
 
Genentech, Inc.
 patents
4. 2 out of 255 
 
Auckland Uniservices Limited
 patents
5. 2 out of 5,515 
 
Leland Stanford Junior University
 patents
6. 2 out of 3 
 
Ruga Corporation
 patents
7. 1 out of 18 
 
Cocensys Inc.
 patents
8. 1 out of 4,488 
 
Pfizer Corporation
 patents
9. 1 out of 1 
 
Psycogenics Inc.
 patent
10. 1 out of 2,432 
 
University of Illinois
 patents
11. 6 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1992-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Agents
GABA Analogs
Cyclic Amino Acids
Pyrazolopyridines
Calcium Channel Blockers
Nicotinic Ligands
Substituted Benzamides
Alkynyl Alcohols
2-Carboxyindoles
Hydrazides
Piperidine Analogs
40 patents (USPTO):Explore Patents
1. 9873709 - Triazolopyridine compounds, compositions and methods of use thereof (2018-01-23),
2. 9605005 - Alkynyl alcohols and methods of use (2017-03-28),
3. 9346815 - 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof (2016-05-24),
4. 9296732 - Substituted benzamides and their uses (2016-03-29),
5. 9085570 - Substituted benzamides and their uses (2015-07-21),
6. 8445684 - Nicotinic acetylcholine receptor ligands and the uses thereof (2013-05-21),
7. 7485636 - Therapeutic pyrazolo[3,4-b]pyridines and indazoles (2009-02-03),
8. 7423054 - Therapeutic pyrazolo[3,4-b]pyridines and indazoles (2008-09-09),
9. 7122678 - Cyclic amino acids and derivatives thereof useful as pharmaceutical agents (2006-10-17),
10. 6921835 - Cyclic amino acids and derivatives thereof useful as pharmaceutical agents (2005-07-26),
11. 6833385 - 3-heteroarylalkyl substituted GABA analogs (2004-12-21),
12. 6710190 - 3-heteroarylalkyl substituted gaba analogs (2004-03-23),
13. 6642398 - Mono-and disubstituted 3-propyl gamma-aminobutyric acids (2003-11-04),
14. 6635673 - Cyclic amino acids and derivatives thereof useful as pharmaceutical agents (2003-10-21),
15. 6525096 - GABA and L-glutamic acid analogs for antiseizure treatment (2003-02-25),

Title: Po-wai Yuen: Innovator in Pharmaceutical Chemistry

Introduction

Po-wai Yuen is a prominent inventor based in Ann Arbor, MI, recognized for his substantial contributions to the field of pharmaceutical chemistry. With an impressive portfolio of 40 patents, his work focuses primarily on compounds that have significant therapeutic applications.

Latest Patents

Yuen's latest patents include innovative research on triazolopyridine compounds, compositions, and their applications as Janus kinase inhibitors. These compounds are specifically outlined as Formula 0, Formula I, and Formula II, showcasing Yuen's expertise in medicinal chemistry. Additionally, he has also developed alkynyl alcohols and the methods of use for these compounds, further expanding his repertoire of impactful inventions.

Career Highlights

Throughout his career, Po-wai Yuen has worked with notable organizations, including Warner-Lambert Company and Northwestern University. His experience in these institutions has allowed him to apply his research to real-world challenges, making significant advancements in drug development.

Collaborations

Yuen has collaborated with several esteemed professionals in his field, including Richard B. Silverman and Ryszard Andruszkiewicz. These collaborations have been instrumental in driving innovation and enhancing the quality of pharmaceutical research and development.

Conclusion

With his extensive number of patents and collaborative efforts, Po-wai Yuen continues to be an influential figure in the realm of drug discovery and development. His work not only exemplifies innovation in pharmaceutical chemistry but also contributes to better health solutions for society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…